Munich, August 1, 2025 – With its Omnichannel Patient Engagement Suite, Temedica introduces an innovative solution that creates an entirely new category in patient engagement. The platform empowers pharmaceutical companies to implement patient communication faster, more scalable, and with measurable ROI. Its modular design connects a broad range of relevant channels, ensuring that patients receive personalized support exactly when they need it.
An integral part of the Omnichannel Suite is Clevi, Temedica’s digital patient companion app. Clevi enables indication-specific, personalized support along the patient journey, delivers data-driven insights into patient behavior, and integrates seamlessly with additional channels, existing services, and brand strategies.
Digital companions like Clevi remain valuable tools - but their impact increases exponentially when they become part of an omnichannel approach. With the Omnichannel Patient Engagement Suite, Temedica orchestrates app content, messaging channels, and patient services through its proprietary data and CRM system. This setup personalizes communication based on patient attributes and behavior, achieving more than 15% higher patient engagement compared to standalone app solutions.
For example, medication reminders in the app can automatically be reinforced through follow-up emails or patient support programs - a combination of digital touchpoints and additional services that, in this integrated form, is unique to the market.
“Our Omnichannel Patient Engagement Suite is the first of its kind, defining a completely new category in patient communication. It is specifically designed to best support the individual goals of our pharma partners - whether that means improving therapy adherence, strengthening patient retention, or optimizing outcome metrics.
Based on this foundation, we tailor patient journeys, content, and the entire setup so that each brand achieves the results that matter most to them,”
Gloria Seibert
Founder & Chief Executive Officer at Temedica
With this approach, Temedica can support patients across a wide range of health conditions throughout their entire journey. The omnichannel model ensures that programs and campaigns are implemented consistently, across indications and independent of channel, delivering sustainable value for both patients and partners.
Thanks to its modular structure, pharma partners can implement a holistic support program within just six weeks – significantly faster and more comprehensive than conventional, custom-built software solutions. Temedica thus takes patient engagement to an entirely new level, setting a benchmark for the industry going forward.
Temedica’s infrastructure already supports more than fifteen health areas, offering more than 40 million patients in German-speaking markets alone a personalized omnichannel experience. Features such as dynamic patient profiles, GDPR-compliant consent and preference management, and a next-best-action engine ensure precise, compliant communication. Real-time dashboards link activation, adherence, and outcome metrics directly to commercial KPIs, delivering measurable ROI within the first year.
About Temedica
Temedica is a technology, AI, and data-enabled solution and service provider for the pharma industry, based in Munich. Since 2016, it empowers pharma companies to achieve exceptional brand performance through holistic strategies and tactical execution. Leveraging real‐world insights, configurable AI-powered solutions, and deep medical and commercial expertise, Temedica transforms pharma’s go-to-market challenges into measurable success.
Temedica is backed by a consortium of renowned investors with many years of experience in the biopharmaceutical industry, including the founding investors of BioNTech. For further information, please visit https://temedica.com/
For further information and media inquiries, please contact:
Temedica GmbH
Lisa Scharinger
📞 +49 175 7365791
Now available: Clevi is available free of charge in the app stores.
More information about the app: www.clevi-health.com
More information about the Omnichannel Patient Engagement Suite: www.temedica.com